Peptide radiopharmaceuticals in nuclear medicine.
This article reviews the labelling of peptides that are recognised to be of interest for nuclear medicine or are the subject of ongoing nuclear medicine research. Applications and approaches to the labelling of peptide radiopharmaceuticals are discussed, and drawbacks in their development considered.
Blok
D
D
Leiden University Medical Center, Department of Clinical Pharmacy and Toxicology, LO-P, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.
Feitsma
R I
RI
Vermeij
P
P
Pauwels
E J
EJ
D000818:Animals; D006801:Humans; D007553:Isotope Labeling; D010455:Peptides / Q000138:chemical synthesis; D019275:Radiopharmaceuticals / Q000138:chemical synthesis
D010455:Peptides; D019275:Radiopharmaceuticals